 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P2 trial: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine (clinicaltrials.gov) - Feb 26, 2025
P2, N=400, Not yet recruiting, Sponsor: Kallyope Inc.
- ||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion, Trial completion date, Trial primary completion date: Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Nov 22, 2022
P2, N=156, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
Active, not recruiting --> Completed | Trial completion date: Jun 2023 --> Nov 2022 | Trial primary completion date: Mar 2023 --> Nov 2022
- || elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment closed: Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Sep 7, 2022
P2, N=144, Active, not recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Active, not recruiting --> Completed | Trial completion date: Jun 2023 --> Nov 2022 | Trial primary completion date: Mar 2023 --> Nov 2022 Recruiting --> Active, not recruiting
- ||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Dec 20, 2021
P2, N=144, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- |||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P2 trial: Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Nov 16, 2021
P2, N=144, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
- ||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion, Enrollment change, Trial completion date: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (clinicaltrials.gov) - Jan 31, 2020
P2, N=190, Completed, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=100 --> 190 | Trial completion date: Mar 2020 --> Nov 2019
- || elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion date, Trial primary completion date: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (clinicaltrials.gov) - May 14, 2019
P2, N=100, Active, not recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Active, not recruiting --> Completed | N=100 --> 190 | Trial completion date: Mar 2020 --> Nov 2019 Trial completion date: Jul 2019 --> Mar 2020 | Trial primary completion date: Apr 2019 --> Dec 2019
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion: MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women (clinicaltrials.gov) - Nov 23, 2018
P2, N=375, Completed, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Trial completion date: Jul 2019 --> Mar 2020 | Trial primary completion date: Apr 2019 --> Dec 2019 Active, not recruiting --> Completed
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion: MT-8554 DQT: Definitive QT Study With MT-8554 (clinicaltrials.gov) - Nov 6, 2018
P1, N=48, Completed, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment closed: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (clinicaltrials.gov) - Oct 29, 2018
P2, N=100, Active, not recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Recruiting --> Completed Recruiting --> Active, not recruiting
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion: Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Aug 27, 2018
P2a, N=61, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment closed: MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women (clinicaltrials.gov) - Jul 27, 2018
P2, N=364, Active, not recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment closed: Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Jun 11, 2018
P2a, N=58, Active, not recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P2 trial: Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (clinicaltrials.gov) - Jun 3, 2018
P2, N=100, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P1 trial: MT-8554 DQT: Definitive QT Study With MT-8554 (clinicaltrials.gov) - Mar 19, 2018
P1, N=48, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion, Trial completion date, Trial primary completion date: Mass Balance Study With MT-8554 (clinicaltrials.gov) - Feb 15, 2018
P1, N=6, Completed, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial completion date: Jan 2018 --> Jan 2018 | Trial primary completion date: Jan 2018 --> Jan 2018
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: Mass Balance Study With MT-8554 (clinicaltrials.gov) - Jan 10, 2018
P1, N=6, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Recruiting --> Completed | Trial completion date: Jan 2018 --> Jan 2018 | Trial primary completion date: Jan 2018 --> Jan 2018 Not yet recruiting --> Recruiting
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P1 trial: Mass Balance Study With MT-8554 (clinicaltrials.gov) - Dec 22, 2017
P1, N=6, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women (clinicaltrials.gov) - Oct 16, 2017
P2, N=364, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P2 trial: MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women (clinicaltrials.gov) - Sep 25, 2017
P2, N=364, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.
- |||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Jul 28, 2017
P2a, N=58, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P2a trial: Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - May 31, 2017
P2a, N=58, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms (clinicaltrials.gov) - Feb 13, 2017
P1, N=24, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
Not yet recruiting --> Recruiting Recruiting --> Completed
- elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms (clinicaltrials.gov) - Jul 15, 2016
P1, N=24, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Completed Not yet recruiting --> Recruiting
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P1 trial: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms (clinicaltrials.gov) - Jun 16, 2016
P1, N=24, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion: A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects (clinicaltrials.gov) - Mar 24, 2016
P1, N=28, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
Not yet recruiting --> Recruiting Recruiting --> Completed
- elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects (clinicaltrials.gov) - Mar 5, 2016
P1, N=28, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Completed Not yet recruiting --> Recruiting
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P1 trial: A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects (clinicaltrials.gov) - Feb 5, 2016
P1, N=28, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion: A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects (clinicaltrials.gov) - Jan 6, 2016
P1, N=20, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Trial completion, Trial primary completion date: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects (clinicaltrials.gov) - Jan 6, 2016
P1, N=135, Completed, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Nov 2015
- | elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P1 trial: A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects (clinicaltrials.gov) - Aug 31, 2015
P1, N=20, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
- ||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
Enrollment open: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects (clinicaltrials.gov) - May 29, 2015
P1, N=136, Recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation
Recruiting --> Completed | Trial primary completion date: Aug 2015 --> Nov 2015 Not yet recruiting --> Recruiting
- ||| elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
New P1 trial: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects (clinicaltrials.gov) - Apr 29, 2015
P1, N=136, Not yet recruiting, Sponsor: Mitsubishi Tanabe Pharma Corporation